UPDATE: Rosetta Genomics (ROSG) Ramps On New Buy Rating; Analyst Sees 238% Upside
Tweet Send to a Friend
(Updated - August 23, 2012 7:34 AM EDT)
Shares of Rosetta Genomics (NASDAQ: ROSG) are surging in pre-open trading ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Shares of Rosetta Genomics (NASDAQ: ROSG) are surging in pre-open trading ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
